Thrombomodulin Alfa Withdrawn Phase 2 Trials for Septic / Disseminated Intravascular Coagulation (DIC) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01090115Study to Look at the Effects of ART-123 on Patients With Sepsis and Disseminated Intravascular Coagulation (DIC)